Previously, serum YKL-40 levels have been found to be elevated in morbidly obese patients with various co-morbidities compared to lean, healthy subjects [29], and in morbidly obese T2D patients when compared to morbidly obese but glucose tolerant individuals [30;31]. The gene discussed is CHI3L1; the disease is type 2 diabetes mellitus.